Hans Merks, Fitsum Ghebretinsea, Michela Casanova, Veronique Minard, Susanne Andrea Gatz, Charlotte Firth, Bridget Shaw, Charlotte Gaskell, Emma Gray, Anne Gro Wesenberg Rognlien, Rutger Knops, Martin Campbell, Tristan Pettit, Maria Michelagnoli, Anna Kelsey, Rick van Rijn, Henry Mandeville, M. Jenney, Gianni Bisogno, Julia C. Chisholm. "Determining the recommended phase 2 dose (RP2D) of dose-intense irinotecan combined with IVA chemotherapy (I R IVA) in newly diagnosed very high risk rhabdomyosarcoma: A phase Ib study within the EpSSG Frontline and Relapsed Rhabdomyosarcoma study (FaR-RMS).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.10024